BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
61 results:

  • 1. Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study.
    Sun X; Chen S; Zhao S; Wang J; Cheng H
    Front Endocrinol (Lausanne); 2024; 15():1284472. PubMed ID: 38495789
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study.
    Yang J; Zhou H; Li H; Zhao F; Tong K
    BMC Cancer; 2024 Feb; 24(1):193. PubMed ID: 38347528
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
    Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
    ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
    Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
    J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The diagnostic value of ultrasound on different-sized thyroid nodules based on ACR TI-RADS.
    Li W; Chen J; Ye F; Xu D; Fan X; Yang C
    Endocrine; 2023 Dec; 82(3):569-579. PubMed ID: 37656349
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trial.
    Zhu Y; Liu K; Cao H; Zhu H
    J Ovarian Res; 2023 Aug; 16(1):168. PubMed ID: 37605274
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]    [Full Text] [Related]  

  • 11. Hypocalcemia During Lenvatinib treatment for Advanced Thyroid cancer: Clinical Features and Management in a Real-Life Setting.
    De Leo S; Trevisan M; Colombo C; Moneta C; Giancola N; Fugazzola L
    Thyroid; 2023 Jan; 33(1):74-81. PubMed ID: 36326203
    [No Abstract]    [Full Text] [Related]  

  • 12. Incidental thyroid carcinoma: Correlation between FNAB cytology and pathological examination in 1093 cases.
    Rodrigues MG; da Silva LFF; Araujo-Filho VJF; Mosca LM; Araujo-Neto VJF; Kowalski LP; Carneiro PC
    Clinics (Sao Paulo); 2022; 77():100022. PubMed ID: 35306374
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pregnancy Outcomes in Thyroid cancer Survivors: A Propensity Score-Matched Cohort Study.
    Cao Q; Zhu H; Zhang J; Li Y; Huang W
    Front Endocrinol (Lausanne); 2022; 13():816132. PubMed ID: 35250872
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Adenosquamous cancer of the pancreas: A multicenter retrospective study.
    Ramia-Angel JM; Jaén-Torrejimeno I; Serrablo-Requejo A; Rodríguez-Laiz GP; López-Guerra D; Abadía-Forcén T; Alenda C; Serradilla-Martín M; Blanco-Fernández G
    Gastroenterol Hepatol; 2022; 45(7):543-551. PubMed ID: 34952130
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Day of surgery and mortality after pancreatoduodenectomy: A retrospective analysis of 29 270 surgical cases of pancreatic head cancer from Japan.
    Uemura S; Endo H; Ichihara N; Miyata H; Maeda H; Hasegawa H; Kamiya K; Kakeji Y; Yoshida K; Yasuyuki S; Yamaue H; Yamamoto M; Kitagawa Y; Hanazaki K
    J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):778-784. PubMed ID: 34496150
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. foxl2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?
    Pilsworth JA; Todeschini AL; Neilson SJ; Cochrane DR; Lai D; Anttonen M; Heikinheimo M; Huntsman DG; Veitia RA
    J Pathol; 2021 Nov; 255(3):225-231. PubMed ID: 34338304
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors.
    Hillman RT; Lin DI; Lawson B; Gershenson DM
    Gynecol Oncol; 2021 Sep; 162(3):728-734. PubMed ID: 34238613
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
    Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
    Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. foxl2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
    Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
    Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. FOXO1 mitigates the SMAD3/foxl2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.